Description: Doxofylline is a novel bronchodilator xanthine that differs from theophylline for the presence of a dioxalane group in position 7.
Indication: For the treatment of COPD (Chronic obstructive pulmonary disease), Bronchial asthma and pulmonary disease with spastic bronchial component.